End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
5.7
CNY
|
+2.52%
|
|
+7.34%
|
-16.18%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,629
|
3,195
|
3,417
|
4,454
|
3,616
|
3,278
|
Enterprise Value (EV)
1 |
2,873
|
3,406
|
3,807
|
5,649
|
5,251
|
5,448
|
P/E ratio
|
52.3
x
|
29.3
x
|
29.1
x
|
21.7
x
|
41.9
x
|
108
x
|
Yield
|
0.83%
|
0.63%
|
0.86%
|
0.9%
|
0.93%
|
1.03%
|
Capitalization / Revenue
|
1.58
x
|
2.03
x
|
2.1
x
|
2.23
x
|
1.1
x
|
1.07
x
|
EV / Revenue
|
1.73
x
|
2.17
x
|
2.34
x
|
2.83
x
|
1.6
x
|
1.77
x
|
EV / EBITDA
|
17.3
x
|
16
x
|
16.5
x
|
23.7
x
|
36
x
|
30.1
x
|
EV / FCF
|
25.4
x
|
-49.6
x
|
-7.18
x
|
-5.03
x
|
-33.3
x
|
-12.1
x
|
FCF Yield
|
3.94%
|
-2.02%
|
-13.9%
|
-19.9%
|
-3%
|
-8.26%
|
Price to Book
|
1.46
x
|
1.71
x
|
1.76
x
|
1.84
x
|
1.43
x
|
1.29
x
|
Nbr of stocks (in thousands)
|
419,231
|
419,231
|
419,231
|
472,836
|
482,115
|
482,115
|
Reference price
2 |
6.270
|
7.620
|
8.150
|
9.420
|
7.500
|
6.800
|
Announcement Date
|
4/28/19
|
2/28/20
|
3/8/21
|
3/28/22
|
3/29/23
|
3/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,660
|
1,571
|
1,626
|
1,997
|
3,275
|
3,077
|
EBITDA
1 |
166.2
|
213.1
|
230.2
|
238.8
|
145.7
|
181.2
|
EBIT
1 |
85.32
|
134.8
|
160.1
|
193.2
|
52.04
|
-7.232
|
Operating Margin
|
5.14%
|
8.58%
|
9.84%
|
9.68%
|
1.59%
|
-0.24%
|
Earnings before Tax (EBT)
1 |
84.18
|
159.7
|
111.5
|
200.7
|
45.96
|
-73.91
|
Net income
1 |
52.33
|
110.1
|
116.4
|
206.2
|
86.4
|
30.33
|
Net margin
|
3.15%
|
7.01%
|
7.16%
|
10.33%
|
2.64%
|
0.99%
|
EPS
2 |
0.1200
|
0.2600
|
0.2800
|
0.4344
|
0.1792
|
0.0629
|
Free Cash Flow
1 |
113.2
|
-68.7
|
-530.6
|
-1,123
|
-157.5
|
-450.2
|
FCF margin
|
6.82%
|
-4.37%
|
-32.63%
|
-56.24%
|
-4.81%
|
-14.63%
|
FCF Conversion (EBITDA)
|
68.15%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
216.4%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0520
|
0.0480
|
0.0700
|
0.0850
|
0.0700
|
0.0700
|
Announcement Date
|
4/28/19
|
2/28/20
|
3/8/21
|
3/28/22
|
3/29/23
|
3/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
245
|
212
|
391
|
1,195
|
1,635
|
2,169
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.474
x
|
0.9942
x
|
1.697
x
|
5.004
x
|
11.22
x
|
11.97
x
|
Free Cash Flow
1 |
113
|
-68.7
|
-531
|
-1,123
|
-157
|
-450
|
ROE (net income / shareholders' equity)
|
3.13%
|
6.08%
|
4.39%
|
8.46%
|
2.53%
|
-3.34%
|
ROA (Net income/ Total Assets)
|
1.79%
|
2.84%
|
2.86%
|
2.5%
|
0.49%
|
-0.06%
|
Assets
1 |
2,920
|
3,876
|
4,076
|
8,238
|
17,501
|
-49,480
|
Book Value Per Share
2 |
4.310
|
4.450
|
4.630
|
5.110
|
5.250
|
5.270
|
Cash Flow per Share
2 |
1.050
|
0.9500
|
1.220
|
1.540
|
1.740
|
1.420
|
Capex
1 |
80.7
|
212
|
827
|
1,132
|
644
|
457
|
Capex / Sales
|
4.86%
|
13.51%
|
50.84%
|
56.67%
|
19.65%
|
14.86%
|
Announcement Date
|
4/28/19
|
2/28/20
|
3/8/21
|
3/28/22
|
3/29/23
|
3/29/24
|
|
1st Jan change
|
Capi.
|
---|
| -16.18% | 374M | | +14.70% | 65.04B | | -1.61% | 47.76B | | +14.58% | 40.72B | | +20.84% | 26.88B | | +9.54% | 19.29B | | +1.16% | 17.53B | | -21.87% | 16.03B | | +1.11% | 15.17B | | -11.34% | 15.06B |
Other Specialty Chemicals
|